विधियों की तुलना करें

	इरिटेबल बाउल सिंड्रोम (IBS) के लिए रोम IV नैदानिक ​​मानदंड	GERD स्वास्थ्य-संबंधित जीवन की गुणवत्ता स्केल
क्षेत्र	जठरांत्र विज्ञान	जठरांत्र विज्ञान
परिवार	Process / pipeline	Process / pipeline
उद्भव वर्ष	2016	1996
प्रवर्तक	Rome Foundation (multinational expert consensus)	Velanovich, V., Zhang, Y., Hollis, J. B., et al.
प्रकार	Diagnostic Criteria	Self-report
मौलिक स्रोत	Mearin, F., Lacy, B. E., Chang, L., et al. (2016). Bowel disorders. Gastroenterology. Published online June 2016 by the Rome Foundation.	Velanovich, V., Zhang, Y., Hollis, J. B., Feldman, M. I., Sampliner, R., Guan, W., & Escamilla, C. (1996). Presenting symptoms and outcome measures in reflux esophagitis. Digestive Diseases and Sciences, 41(10), 1865–1873.
उपनाम	Rome IV IBS, Rome Criteria	GERD-HRQL, GERD-HRQoL
संबंधित	4	4
सारांश	The Rome IV criteria are the internationally accepted diagnostic standard for irritable bowel syndrome (IBS), published in 2016 by the Rome Foundation. These criteria define IBS as recurrent abdominal pain (≥1 day per week for ≥3 months) associated with altered bowel habits, without structural or biochemical abnormalities. IBS is subtyped into four patterns—IBS-constipation predominant (IBS-C), IBS-diarrhea predominant (IBS-D), IBS-mixed (IBS-M), and IBS-unclassified (IBS-U)—based on stool consistency patterns.	The GERD Health-Related Quality of Life Scale (GERD-HRQL) is a concise, validated patient-reported outcome measure for assessing the symptomatic and functional impact of gastroesophageal reflux disease (GERD). Developed by Velanovich and colleagues in 1996, the 9-item GERD-HRQL measures heartburn frequency and severity, regurgitation, and impact on sleep and medication use. The scale is highly responsive to proton pump inhibitor (PPI) therapy and is widely used in GERD trials and clinical practice.